Finley John David bought PALI
July 6, 2026 · Form 4 insider transaction
Finley John David bought 335,167 shares of Palisade Bio, Inc., a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
335,167
Price
N/A
Total value
N/A
InsiderFinley John David
Role—
CompanyPalisade Bio, Inc. (PALI)
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJuly 6, 2026
Filing dateJuly 8, 2026
Shares owned after364,353
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs") granted on February 9, 2026.; Includes 1,899 shares acquired under the Issuer's Employee Stock Purchase Plan on May 20, 2026. In addition, the amount of securities beneficially owned was reduced by 66 shares due to an administrative error in the total reported in the Form 4 filed February 13, 2026.